| Inhibiting SUMO1-mediated SUMOylation induces autophagy-mediated cancer cell death and reduces tumour cell invasion via RAC1 M Lorente, A García-Casas, N Salvador, A Martínez-López, ... Journal of cell science 132 (20), jcs234120, 2019 | 39 | 2019 |
| Further the liquid biopsy: gathering pieces of the puzzle of genometastasis theory A García-Casas, DC García-Olmo, D García-Olmo World journal of clinical oncology 8 (5), 378, 2017 | 28 | 2017 |
| Stromal SNAI2 is required for ERBB2 breast cancer progression A Blanco-Gómez, L Hontecillas-Prieto, R Corchado-Cobos, ... Cancer research 80 (23), 5216-5230, 2020 | 21 | 2020 |
| Synthesis and Evaluation of Ginkgolic Acid Derivatives as SUMOylation Inhibitors CM Brackett, A García-Casas, S Castillo-Lluva, BSJ Blagg ACS Medicinal Chemistry Letters 11 (11), 2221-2226, 2020 | 15 | 2020 |
| Inhibition of RAC1 activity in cancer associated fibroblasts favours breast tumour development through IL-1β upregulation A Martínez-López, A García-Casas, P Bragado, A Orimo, ... Cancer Letters 521, 14-28, 2021 | 10 | 2021 |
| POTEE promotes breast cancer cell malignancy by inducing invadopodia formation through the activation of SUMOylated Rac1 A Martínez‐López, A García‐Casas, G Infante, M González‐Fernández, ... Molecular Oncology 18 (3), 620-640, 2024 | 2 | 2024 |
| Estudio del papel que desempaña la sumoilación de Rac1 en la diseminación del cáncer de mama A García Casas Universidad Complutense de Madrid, 2024 | | 2024 |
| NCAPH drives breast cancer progression and identifies a gene signature that predicts luminal a tumour recurrence M Mendiburu‐Eliçabe, N García‐Sancha, R Corchado‐Cobos, ... Clinical and Translational Medicine 14 (2), e1554, 2024 | | 2024 |
| A 10-gene signature associated with elevated levels of NCAPH identifies luminal A breast cancer patients with a risk of relapse M Mendiburu-Eliçabe, N García-Sancha, R Corchado-Cobos, ... | | 2023 |
